National Bank of Canada
PROF

National Bank of Canada’s Profound Medical PROF Stock Holding History

National Bank of Canada’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
218,698
+1,523
+0.7% +$10.2K ﹤0.01% 1234
2026
Q1 		$1.34M Buy
217,175
+27,665
+15% +$191K ﹤0.01% 1176
2025
Q4 		$1.42M Buy
189,510
+16,627
+10% +$107K ﹤0.01% 1134
2025
Q3 		$845K Buy
172,883
+11,704
+7% +$59.7K ﹤0.01% 1238
2025
Q2 		$956K Buy
161,179
+24,053
+18% +$127K ﹤0.01% 1295
2025
Q1 		$667K Buy
137,126
+10,618
+8% +$73.3K ﹤0.01% 1262
2024
Q4 		$951K Buy
126,508
+4,671
+4% +$35.9K ﹤0.01% 1316
2024
Q3 		$970K Sell
121,837
-6,433
-5% -$58.1K ﹤0.01% 1111
2024
Q2 		$1.07M Buy
128,270
+241
+0.2% +$1.94K ﹤0.01% 1048
2024
Q1 		$960K Buy
128,029
+1,301
+1% +$10.9K ﹤0.01% 1140
2023
Q4 		$1.01M Sell
126,728
-1,413
-1% -$13.4K ﹤0.01% 1147
2023
Q3 		$1.21M Buy
128,141
+2,458
+2% +$25.5K ﹤0.01% 1149
2023
Q2 		$1.6M Sell
125,683
-1,644
-1% -$20.4K ﹤0.01% 1036
2023
Q1 		$1.17M Sell
127,327
-772,150
-86% -$8.93M ﹤0.01% 999
2022
Q4 		$9.83M Buy
899,477
+2,749
+0.3% +$15K 0.03% 431
2022
Q3 		$3.74M Buy
896,728
+778,386
+658% +$5.25M 0.02% 614
2022
Q2 		$840K Buy
118,342
+4,727
+4% +$37.4K ﹤0.01% 1068
2022
Q1 		$1.01M Buy
113,615
+33,955
+43% +$327K ﹤0.01% 1110
2021
Q4 		$722K Buy
+79,660
New +$995K ﹤0.01% 1155

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

National Bank of Canada's PROF Position: Q2 2026 in Review

National Bank of Canada increased its Profound Medical (PROF) stake by 0.7% in Q2 2026, buying an estimated $10.2K and bringing the position to 218,698 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

National Bank of Canada first reported a position in PROF in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.83M in Q4 2022. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • National Bank of Canada held 218,698 shares of Profound Medical worth $1.25M as of Q2 2026.
  • National Bank of Canada bought 1,523 Profound Medical shares in Q2 2026, an estimated $10.2K.
  • Profound Medical made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1234 holding.
  • National Bank of Canada first reported a position in Profound Medical in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Profound Medical position peaked at $9.83M in Q4 2022.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.